← Back to Browse
ProductDiagnostic Tests

HE4 and CA125 Combined Assay

China

In vitro diagnostic assay measuring HE4 and CA125 biomarkers for evaluation of endometrial-like cancer lymph node metastasis. This combined marker approach provides improved diagnostic accuracy for gynecological malignancies.

Manufactured by

China

CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
54 relevant products
2United States
15 relevant products
3Germany
6 relevant products
🔒

12 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 103 closest product alternatives

103 products

100 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products